EIGER BIOPHARMACEUTICALS INC (EIGR) Forecast, Price Target & Analyst Ratings

NASDAQ:EIGR • US28249U2042

Current stock price

1.725 USD
-0.17 (-9.21%)
At close:
1.7 USD
-0.03 (-1.45%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EIGER BIOPHARMACEUTICALS INC (EIGR).

Forecast Snapshot

Consensus Price Target

Price Target
$91.80
+ 5,221.74% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2024
EPS Estimate
-$5.51
Revenue Estimate
5.659M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$91.80
Upside
+ 5,221.74%
From current price of $1.73 to mean target of $91.80, Based on 8 analyst forecasts
Low
$30.30
Median
$91.80
High
$157.50

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for EIGR. The average price target is 91.8 USD. This implies a price increase of 5221.74% is expected in the next year compared to the current price of 1.725.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

EIGR Current Analyst RatingEIGR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

EIGR Historical Analyst RatingsEIGR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
87.50%
EIGR was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about EIGR.
In the previous month the buy percentage consensus was at a similar level.
EIGR was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-08-29CitigroupMaintains Buy -> Buy
2023-06-30BairdMaintains Outperform -> Outperform
2022-09-07BTIGMaintains Buy
2021-08-09CitigroupMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2024
EPS Estimate
-$5.51
Revenue Estimate
5.659M
Revenue Q2Q
37.42%
EPS Q2Q
64.69%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
-159.02%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
EIGR revenue by date.EIGR revenue by date.
12.14M13.48M
11.04%		15.773M
17.01%		25.722M
63.08%		33.307M
29.49%		35.044M
5.22%		36.874M
5.22%		56.937M
54.41%		165.05M
189.88%		273.77M
65.87%
EBITDA
YoY % growth
EIGR ebitda by date.EIGR ebitda by date.
-76.66M
-23.69%		-92.45M
-20.60%		-71.503M
22.66%		5.161M
107.22%		-45.837M
-988.14%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
EIGR ebit by date.EIGR ebit by date.
-76.94M
-23.80%		-92.74M
-20.54%		-71.778M
22.60%		-21.971M
69.39%		-6.345M
71.12%		-5.142M
18.97%		-4.205M
18.21%		14.416M
442.79%		117.53M
715.27%		223.34M
90.03%
Operating Margin
EIGR operating margin by date.EIGR operating margin by date.
-633.77%-687.98%-455.07%-85.42%-19.05%-14.67%-11.40%25.32%71.21%81.58%
EPS
YoY % growth
EIGR eps by date.EIGR eps by date.
-2.37
-2.60%		-18.87
-696.20%		N/A
-165.95%		-15.91
68.29%		-3.67
76.92%		-0.10
97.22%		-0.09
10.00%		0.12
233.33%		1.34
991.67%		2.52
88.55%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-5.51
64.69%		-3.98
71.79%		-3.67
70.15%		-2.75
64.00%
Revenue
Q2Q % growth		5.659M
37.42%		6.173M
33.04%		6.688M
108.35%		7.202M
89.38%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-7.364M
66.90%		-5.25M
73.72%		-4.868M
71.24%		-4.487M
64.43%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EIGR Yearly Revenue VS EstimatesEIGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
EIGR Yearly EPS VS EstimatesEIGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.95%
EPS Next 5 Year
14.90%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
23.14%
Revenue Next 5 Year
24.85%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

EIGER BIOPHARMACEUTICALS INC / EIGR Forecast FAQ

What do analysts expect the price target to be for EIGER BIOPHARMACEUTICALS INC (EIGR)?

8 analysts have analysed EIGR and the average price target is 91.8 USD. This implies a price increase of 5221.74% is expected in the next year compared to the current price of 1.725.

What are the consensus estimates for EIGER BIOPHARMACEUTICALS INC (EIGR) next earnings?

The consensus EPS estimate for the next earnings of EIGER BIOPHARMACEUTICALS INC (EIGR) is -5.51 USD and the consensus revenue estimate is 5.66M USD.

How many analysts cover EIGER BIOPHARMACEUTICALS INC (EIGR) stock?

The number of analysts covering EIGER BIOPHARMACEUTICALS INC (EIGR) is 8.